This Healthcare Stock Is Trading Lower By 29%: Here Are 29 Stocks Moving Premarket

Gainers

• Plus Therapeutics, Inc. (NASDAQ:PSTV) shares rose 88.7% to $1.04 in pre-market trading after the company was awarded $17.6 million from State of Texas for continued development of co.'s lead investigational targeted radiotherapeutic Rhenium-186 NanoLiposome for the treatment of patients with leptomeningeal metastases.
• Codiak BioSciences, Inc. (NASDAQ:CDAK) shares rose 42.4% to $3.29 in pre-market trading. Codiak BioSciences recently posted a Q2 loss of $0.30 per share.
• Wolfspeed, Inc. (NYSE:WOLF) rose 20.7% to $103.40 in pre-market trading after the company reported better-than-expected Q4 results.
• Vinco Ventures, Inc. (NASDAQ:BBIG) rose 16.6% to $1.62 in pre-market trading after jumping 23% on Wednesday.
• bluebird bio, Inc. (NASDAQ:BLUE) shares rose 13.5% to $7.70 in pre-market trading. The FDA has approved Bluebird bio’s Zynteglo (betibeglogene autotemcel), also known as beti-cel, a one-time gene therapy custom-designed for beta‑thalassemia.
• Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) rose 13.1% to $0.2425 in pre-market trading after declining 12% on Wednesday. Corbus Pharmaceuticals recently posted a Q2 loss of $0.11 per share.
• Applied DNA Sciences, Inc. (NASDAQ:APDN) rose 12.9% to $4.19 in pre-market trading after climbing 11% on Wednesday. Applied DNA Sciences recently posted a Q3 loss of $0.13 per share.
• Endo International plc (NASDAQ:ENDP) rose 10.2% to $0.3128 in pre-market trading after dipping 23% on Wednesday. Endo International filed for bankruptcy after reaching a $6 billion deal with some of its creditors as the company sought to settle opioid-related lawsuits.
• Privia Health Group, Inc. (NASDAQ:PRVA) rose 9.7% to $39.40 in pre-market trading. Privia Health, last week, said Q2 EPS results were higher year over year.
• Fate Therapeutics, Inc. (NASDAQ:FATE) rose 9.4% to $33.06 in pre-market trading after declining 8% on Wednesday.
• Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) shares rose 9.4% to $0.8195 in pre-market trading after gaining 10% on Wednesday. Mind Medicine recently posted a Q2 loss of $0.04 per share.
• Grindrod Shipping Holdings Ltd. (NASDAQ:GRIN) rose 9.3% to $20.95 in pre-market trading. Grindrod Shipping reported a second-quarter revenue increase of 47.1% year-over-year to $161.58 million.
• Palisade Bio, Inc.(NASDAQ:PALI) rose 9.2% to $0.1780 in pre-market trading after dropping 21% on Wednesday. Palisade Bio dosed first patient in its Phase 3 study evaluating lead asset LB1148 to accelerate the return of bowel function in adult patients undergoing gastrointestinal surgery.
• Performance Shipping Inc. (NASDAQ:PSHG) rose 9.1% to $0.3380 in pre-market trading after declining 13% on Wednesday. Performance Shipping recently priced its 33 million share offering at $0.45 per share.
• Jupiter Wellness, Inc. (NASDAQ:JUPW) shares rose 9.1% to $0.70 in pre-market trading. Jupiter Wellness recently reported a second-quarter FY22 sales jump of 400% year-on-year, to $3 million, versus $0.6 million last year..
• Verb Technology Company, Inc. (NASDAQ:VERB) rose 8.2% to $0.53 in pre-market trading. Verb Technology recently reported Q2 total digital revenue of $2.2 million.
• Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) rose 5.7% to $49.94 in pre-market trading. Ultragenyx reported inducement grant under Nasdaq Listing Rule 5635(c)(4).
• Keysight Technologies, Inc. (NYSE:KEYS) rose 4.4% to $176.72 in pre-market trading as the company reported upbeat earnings for its third quarter and issued a strong forecast for the fourth quarter.
• Cisco Systems, Inc. (NASDAQ:CSCO) rose 4.2% to $48.62 in pre-market trading after the company reported better-than-expected results for its fourth quarter and issued strong guidance.